Annual D&A
$151.00 K
-$216.00 K-58.86%
December 31, 2023
Summary
- As of February 12, 2025, CRVS annual depreciation & amortization is $151.00 thousand, with the most recent change of -$216.00 thousand (-58.86%) on December 31, 2023.
- During the last 3 years, CRVS annual D&A has fallen by -$481.00 thousand (-76.11%).
- CRVS annual D&A is now -82.17% below its all-time high of $847.00 thousand, reached on December 31, 2018.
Performance
CRVS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$21.00 K
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, CRVS quarterly depreciation & amortization is $21.00 thousand, unchanged on September 30, 2024.
- Over the past year, CRVS quarterly D&A has dropped by -$9000.00 (-30.00%).
- CRVS quarterly D&A is now -90.79% below its all-time high of $228.00 thousand, reached on September 30, 2018.
Performance
CRVS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$93.00 K
-$9000.00-8.82%
September 30, 2024
Summary
- As of February 12, 2025, CRVS TTM depreciation & amortization is $93.00 thousand, with the most recent change of -$9000.00 (-8.82%) on September 30, 2024.
- Over the past year, CRVS TTM D&A has dropped by -$124.00 thousand (-57.14%).
- CRVS TTM D&A is now -89.50% below its all-time high of $886.00 thousand, reached on September 30, 2018.
Performance
CRVS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CRVS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.9% | -30.0% | -57.1% |
| 3 y3 years | -76.1% | -77.7% | -74.7% |
| 5 y5 years | -82.2% | -77.7% | -74.7% |
CRVS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.2% | at low | -77.7% | at low | -79.8% | at low |
| 5 y | 5-year | -79.7% | at low | -88.7% | at low | -87.5% | at low |
| alltime | all time | -82.2% | +2.0% | -90.8% | +2000.0% | -89.5% | +9200.0% |
Corvus Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $21.00 K(0.0%) | $93.00 K(-8.8%) |
| Jun 2024 | - | $21.00 K(-8.7%) | $102.00 K(-12.8%) |
| Mar 2024 | - | $23.00 K(-17.9%) | $117.00 K(-22.5%) |
| Dec 2023 | $151.00 K(-58.9%) | $28.00 K(-6.7%) | $151.00 K(-30.4%) |
| Sep 2023 | - | $30.00 K(-16.7%) | $217.00 K(-22.8%) |
| Jun 2023 | - | $36.00 K(-36.8%) | $281.00 K(-16.6%) |
| Mar 2023 | - | $57.00 K(-39.4%) | $337.00 K(-8.2%) |
| Dec 2022 | $367.00 K(-20.2%) | $94.00 K(0.0%) | $367.00 K(+0.3%) |
| Sep 2022 | - | $94.00 K(+2.2%) | $366.00 K(-3.7%) |
| Jun 2022 | - | $92.00 K(+5.7%) | $380.00 K(-7.3%) |
| Mar 2022 | - | $87.00 K(-6.5%) | $410.00 K(-10.9%) |
| Dec 2021 | $460.00 K(-27.2%) | $93.00 K(-13.9%) | $460.00 K(-9.6%) |
| Sep 2021 | - | $108.00 K(-11.5%) | $509.00 K(-7.1%) |
| Jun 2021 | - | $122.00 K(-10.9%) | $548.00 K(-6.3%) |
| Mar 2021 | - | $137.00 K(-3.5%) | $585.00 K(-7.4%) |
| Dec 2020 | $632.00 K(-14.9%) | $142.00 K(-3.4%) | $632.00 K(-6.4%) |
| Sep 2020 | - | $147.00 K(-7.5%) | $675.00 K(-5.5%) |
| Jun 2020 | - | $159.00 K(-13.6%) | $714.00 K(-3.6%) |
| Mar 2020 | - | $184.00 K(-0.5%) | $741.00 K(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $743.00 K(-12.3%) | $185.00 K(-0.5%) | $743.00 K(+0.7%) |
| Sep 2019 | - | $186.00 K(0.0%) | $738.00 K(-5.4%) |
| Jun 2019 | - | $186.00 K(0.0%) | $780.00 K(-4.2%) |
| Mar 2019 | - | $186.00 K(+3.3%) | $814.00 K(-3.9%) |
| Dec 2018 | $847.00 K(+0.6%) | $180.00 K(-21.1%) | $847.00 K(-4.4%) |
| Sep 2018 | - | $228.00 K(+3.6%) | $886.00 K(+2.0%) |
| Jun 2018 | - | $220.00 K(+0.5%) | $869.00 K(+1.4%) |
| Mar 2018 | - | $219.00 K(0.0%) | $857.00 K(+1.8%) |
| Dec 2017 | $842.00 K(+41.8%) | $219.00 K(+3.8%) | $842.00 K(+4.2%) |
| Sep 2017 | - | $211.00 K(+1.4%) | $808.00 K(+6.9%) |
| Jun 2017 | - | $208.00 K(+2.0%) | $756.00 K(+9.2%) |
| Mar 2017 | - | $204.00 K(+10.3%) | $692.00 K(+16.5%) |
| Dec 2016 | $594.00 K(+301.4%) | $185.00 K(+16.4%) | $594.00 K(+27.5%) |
| Sep 2016 | - | $159.00 K(+10.4%) | $466.00 K(+28.7%) |
| Jun 2016 | - | $144.00 K(+35.8%) | $362.00 K(+43.1%) |
| Mar 2016 | - | $106.00 K(+86.0%) | $253.00 K(+70.9%) |
| Dec 2015 | $148.00 K | $57.00 K(+3.6%) | $148.00 K(+62.6%) |
| Sep 2015 | - | $55.00 K(+57.1%) | $91.00 K(+152.8%) |
| Jun 2015 | - | $35.00 K(+3400.0%) | $36.00 K(+3500.0%) |
| Mar 2015 | - | $1000.00 | $1000.00 |
FAQ
- What is Corvus Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual D&A year-on-year change?
- What is Corvus Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly D&A year-on-year change?
- What is Corvus Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals TTM D&A year-on-year change?
What is Corvus Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CRVS is $151.00 K
What is the all time high annual D&A for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual depreciation & amortization is $847.00 K
What is Corvus Pharmaceuticals annual D&A year-on-year change?
Over the past year, CRVS annual depreciation & amortization has changed by -$216.00 K (-58.86%)
What is Corvus Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CRVS is $21.00 K
What is the all time high quarterly D&A for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly depreciation & amortization is $228.00 K
What is Corvus Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CRVS quarterly depreciation & amortization has changed by -$9000.00 (-30.00%)
What is Corvus Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CRVS is $93.00 K
What is the all time high TTM D&A for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high TTM depreciation & amortization is $886.00 K
What is Corvus Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CRVS TTM depreciation & amortization has changed by -$124.00 K (-57.14%)